Skip to content

Neuroplasticity: all studies

Page 145 of 178: studies 1,441 to 1,450 of 1,772, newest first. Back to the neuroplasticity overview

Research

Psychedelics and Other Psychoplastogens for Treating Mental Illness

Frontiers in Psychiatry October 4, 2021 Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes et al. 162 citations

Psychedelics have inspired new hope for treating brain disorders, as they seem to be unlike any treatments currently available. Not only do they produce sustained therapeutic effects following a single administration, they also appear to have broad therapeutic potential, demonstrating efficacy for treating depression, post-traumatic stress disorder (PTSD), anxiety disorders, substance abuse...

Editorial: “The stuff that dreams are made of”

Journal of Oral & Facial Pain and Headache October 1, 2021 Rafael Benoliel

Rafael Benoliel: Dentistry and specifically orofacial pain have been involved in the science of sleep and its interactions with pain and various other relevant disorders for decades. Yet we have not yet explored dreams; an amazing phenomenon occurring during sleep where brain activity can induce a virtual reality that includes visual, auditory, olfactory, taste, and emotional experiences as...

Acute Delta 9-tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats.

Synapse October 2021 Kyle A Windisch, Sanoara Mazid, Megan A Johnson et al.

Our prior studies demonstrated that the rat hippocampal opioid system can undergo sex-specific adaptations to external stimuli that can influence opioid-associated learning processes. This opioid system extensively overlaps with the cannabinoid system. Moreover, acute administration of Δ9 Tetrahydrocannabinoid (THC), the primary psychoactive constituent of cannabis, can alter cognitive...

DOI: 10.1002/syn.22218 (opens in new tab) Full text (opens in new tab) Delta opioid receptor Hippocampal ca3 Sex differences Δ9-tetrahydrocannabinol

Ketamine in depression and electroconvulsive therapy

Current Opinion in Anaesthesiology October 1, 2021 Irene Rozet 9 citations

Purpose of review The antidepressant effect of subanesthetic doses of ketamine was recognized 20 years ago. This review briefly summarizes the current understanding of the antidepressant mechanisms and the available clinical research on the use of racemic ketamine and enantiomer esketamine for depression. Recent findings The antidepressant effect of subanesthetic doses of ketamine is currently...

Free will – an approach from the perspective of neuroscience

Romanian Journal of Medical Practice September 30, 2021 Adrian Sorin Mihalache, L. Zagrean

Free will designates the possibility of conscious and free choice of the subject, as well as his real possibility to act. The topic has a special medical and social relevance as it is directly connected to how the subject’s responsibility (moral, legal, medical) for his own actions are understood, but also the possibility (real or illusory) of intervention in his own life. Free will has...

Multiple Routes to Animal Consciousness: Constrained Multiple Realizability Rather Than Modest Identity Theory.

Frontiers in Psychology September 24, 2021 Jon Mallatt, Todd E Feinberg

The multiple realizability thesis (MRT) is an important philosophical and psychological concept. It says any mental state can be constructed by multiple realizability (MR), meaning in many distinct ways from different physical parts. The goal of our study is to find if the MRT applies to the mental state of consciousness among animals. Many things have been written about MRT but the ones most...

DOI: 10.3389/fpsyg.2021.732336 (opens in new tab) Full text (opens in new tab) Animal consciousness Convergent evolution Evolutionary constraints Mental phenomena +4

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

Journal of Neurochemistry September 14, 2021 Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr et al. 78 citations

Abstract The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly gaining interest in neuroscience research. Much of this interest stems from recent clinical studies demonstrating that they have a unique ability to improve the debilitating symptoms of major depressive disorder (MDD) long‐term after only a single treatment. Indeed, the Food and Drug...

From many to (n)one: Meditation and the plasticity of the predictive mind.

Neuroscience & Biobehavioral Reviews September 1, 2021 Ruben Laukkonen, Heleen A. Slagter 183 citations

How profoundly can humans change their own minds? In this paper we offer a unifying account of deconstructive meditation under the predictive processing view. We start from simple axioms. First, the brain makes predictions based on past experience, both phylogenetic and ontogenetic. Second, deconstructive meditation brings one closer to the here and now by disengaging anticipatory processes. We...

Low Doses of Ketamine and Melatonin in Combination Produce Additive Antidepressant-like Effects in Mice

International Journal of Molecular Sciences August 26, 2021 Rosa Estrada-Reyes, Daniel B Quero-Chávez, Citlali Trueta et al.

Major depressive disorder is a disabling disease with the number of affected individuals increasing each year. Current antidepressant treatments take between three to six weeks to be effective with forty percent of patients being resistant to treatment, making it necessary to search for new antidepressant treatments. Ketamine, a phencyclidine hydrochloride derivative, given intravenously,...

Ready for a "breakthrough" with ketamine? A look at recent pharmacological insights!

Current Opinion in Anaesthesiology August 1, 2021 Sabine Himmelseher, Eberhard F Kochs

To update pharmacological insights on ketamine integrating information from different disciplines for developing steps to "breakthrough" approaches in clinical challenges. Pharmacokinetic/pharmacodynamic (PK/PD) models have incorporated recirculation, ketamine metabolites, drug-drug interaction, and covariates such as age. Ketamine-induced relief from treatment-resistant depression has been...